Alkermes
ALKS
#3194
Rank
โ‚ฌ3.99 B
Marketcap
23,96ย โ‚ฌ
Share price
-1.25%
Change (1 day)
-24.14%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): โ‚ฌ0.36 Billion

According to Alkermes's latest financial reports the company's current earnings are โ‚ฌ1.52 Billion. In 2024 the company made an earning of โ‚ฌ0.40 Billion a decrease over its 2023 earnings that were of โ‚ฌ0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.36 B-9.42%
2024 โ‚ฌ0.40 B-17.97%
2023 โ‚ฌ0.49 B-468.52%
2022 -โ‚ฌ0.14 Billion449.24%
2021 -โ‚ฌ24.35 Million-68.04%
2020 -โ‚ฌ76.16 Million-52.1%
2019 -โ‚ฌ0.16 Billion64.49%
2018 -โ‚ฌ96.66 Million-15.04%
2017 -โ‚ฌ0.12 Billion-34.2%
2016 -โ‚ฌ0.18 Billion-5.34%
2015 -โ‚ฌ0.19 Billion35084.97%
2014 -โ‚ฌ0.52 Million
2012 โ‚ฌ6.43 M-117.81%
2011 -โ‚ฌ36.13 Million-12.69%
2010 -โ‚ฌ41.38 Million94.3%
2009 -โ‚ฌ21.3 Million-117.7%
2008 โ‚ฌ0.12 B622.63%
2007 โ‚ฌ16.64 M
2004 -โ‚ฌ65.84 Million-14.48%
2003 -โ‚ฌ76.99 Million11.88%
2002 -โ‚ฌ68.82 Million39.65%
2001 -โ‚ฌ49.28 Million5.73%
2000 -โ‚ฌ46.61 Million-28.91%
1999 -โ‚ฌ65.56 Million237.28%
1998 -โ‚ฌ19.44 Million100.05%
1997 -โ‚ฌ9.72 Million-37.93%
1996 -โ‚ฌ15.66 Million82.72%
1995 -โ‚ฌ8.57 Million-26.79%
1994 -โ‚ฌ11.7 Million-72.78%
1993 -โ‚ฌ42.99 Million208.07%
1992 -โ‚ฌ13.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.07 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.17 B 3,931.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ10.27 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.88 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ6.96 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.34 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-โ‚ฌ0.19 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚ฌ0.24 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.86 B 430.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel